Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial
Year: 2001
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
Authors: A. Keith Stewart, Robert Vescio, Gary Schiller, Oscar Ballester, Stephen Noga, Hope Rugo, Cesar Freytes, Edward Stadtmauer, Stefano Tarantolo, Firoozeh Sahebi, Pat Stiff, Jacinta Meharchard, Robert Schlossman, Randy Brown, Heather Tully, Mark Benyunes, Cindy Jacobs, Ronald Berenson, Michael White, John DiPersio, Kenneth C. Anderson, James Berenson
Institutions: Johns Hopkins University, University of California, Los Angeles, University of California, San Francisco, University of South Florida, Princess Margaret Cancer Centre, VA West Los Angeles Medical Center, The University of Texas at San Antonio, University of Pennsylvania, Princess Margaret Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1922664920
